Hypothesis

3 Matching Annotations

Last 7 days
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

Anti-myeloma activity of the CXCR4 antagonist WZ811

1
1. scibot 20 Feb 2026
  
  in Public
  
  RRID:CVCL_E332
  
  DOI: 10.1007/s00109-026-02650-4
  
  Resource: (RRID:CVCL_E332)
  
  Curator: @evieth
  
  SciCrunch record: RRID:CVCL_E332
  
  What is this?
  
  RRID:CVCL_E332
Visit annotations in context

Tags

RRID:CVCL_E332

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC12913330/
Jul 2024
www.sciencedirect.com www.sciencedirect.com

IRF4 requires ARID1A to establish plasma cell identity in multiple myeloma

1
1. scibot 24 Jul 2024
  
  in Public
  
  RRID:CVCL_E332
  
  DOI: 10.1016/j.ccell.2024.05.026
  
  Resource: (RRID:CVCL_E332)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_E332
  
  What is this?
  
  RRID:CVCL_E332
Visit annotations in context

Tags

RRID:CVCL_E332

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1535610824002174
Mar 2022
www.sciencedirect.com www.sciencedirect.com

Indirubin-3’-monoxime acts as proteasome inhibitor: Therapeutic application in multiple myeloma

1
1. scibot 27 Mar 2022
  
  in Public
  
  CVCL_E332
  
  DOI: 10.1016/j.ebiom.2022.103950
  
  Resource: (RRID:CVCL_E332)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_E332
  
  What is this?
  
  RRID:CVCL_E332
Visit annotations in context

Tags

RRID:CVCL_E332

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2352396422001347